Rupa Mazumder

1.3k total citations
140 papers, 937 citations indexed

About

Rupa Mazumder is a scholar working on Molecular Biology, Pharmaceutical Science and Plant Science. According to data from OpenAlex, Rupa Mazumder has authored 140 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Pharmaceutical Science and 25 papers in Plant Science. Recurrent topics in Rupa Mazumder's work include Advanced Drug Delivery Systems (18 papers), Synthesis and biological activity (16 papers) and Computational Drug Discovery Methods (16 papers). Rupa Mazumder is often cited by papers focused on Advanced Drug Delivery Systems (18 papers), Synthesis and biological activity (16 papers) and Computational Drug Discovery Methods (16 papers). Rupa Mazumder collaborates with scholars based in India, Nepal and Saudi Arabia. Rupa Mazumder's co-authors include Avijit Mazumder, Sujata G. Dastidar, Salahuddin Salahuddin, Seema Garg, Amrish Chandra, Mohammad Shahar Yar, Mohamed Jawed Ahsan, Rakhi Mishra, Priya Gupta and Shikha Chaudhary and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Biological Macromolecules.

In The Last Decade

Rupa Mazumder

118 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rupa Mazumder India 15 261 210 188 129 110 140 937
Sahabjada Siddiqui India 21 407 1.6× 214 1.0× 142 0.8× 182 1.4× 115 1.0× 69 1.2k
Satish Sardana India 18 194 0.7× 166 0.8× 118 0.6× 63 0.5× 135 1.2× 57 841
D.N. Prasad India 20 401 1.5× 175 0.8× 430 2.3× 104 0.8× 79 0.7× 65 1.2k
Roxana Ghiulai Romania 21 498 1.9× 147 0.7× 112 0.6× 83 0.6× 137 1.2× 41 1.0k
Hezhong Jiang China 17 334 1.3× 230 1.1× 409 2.2× 67 0.5× 59 0.5× 72 1.2k
Manikanta Murahari India 23 468 1.8× 93 0.4× 334 1.8× 94 0.7× 91 0.8× 51 1.2k
Rajesh B. Patil India 17 442 1.7× 92 0.4× 255 1.4× 173 1.3× 83 0.8× 89 1.2k
Camelia Oprean Romania 19 319 1.2× 129 0.6× 142 0.8× 116 0.9× 128 1.2× 33 814
Pritam Jain India 18 233 0.9× 147 0.7× 95 0.5× 69 0.5× 133 1.2× 76 949
Chwan‐Fwu Lin Taiwan 21 368 1.4× 112 0.5× 93 0.5× 113 0.9× 51 0.5× 42 906

Countries citing papers authored by Rupa Mazumder

Since Specialization
Citations

This map shows the geographic impact of Rupa Mazumder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupa Mazumder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupa Mazumder more than expected).

Fields of papers citing papers by Rupa Mazumder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupa Mazumder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupa Mazumder. The network helps show where Rupa Mazumder may publish in the future.

Co-authorship network of co-authors of Rupa Mazumder

This figure shows the co-authorship network connecting the top 25 collaborators of Rupa Mazumder. A scholar is included among the top collaborators of Rupa Mazumder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupa Mazumder. Rupa Mazumder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazumder, Rupa, et al.. (2025). Challenges and Progress of Orphan Drug Development for Rare Diseases. Current Pharmaceutical Biotechnology. 26.
2.
Mazumder, Rupa, et al.. (2024). Search for Novel Therapeutic Targets of Type 2 Diabetes Mellitus. Current Drug Therapy. 20(7). 1001–1018.
3.
Mazumder, Rupa, et al.. (2024). Recent Research Trends against Skin Carcinoma - An Overview. Current Pharmaceutical Design. 30(34). 2685–2700. 1 indexed citations
4.
Kumari, Preeti, Rakhi Mishra, Rupa Mazumder, et al.. (2024). An Insight into Common and Advanced Synthesis Methodologies of Acyl Urea Analogs Targeting the CNS. Letters in Organic Chemistry. 21(12). 1006–1022.
5.
Mazumder, Rupa, et al.. (2024). miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement. Current Gene Therapy. 25(4). 360–373. 2 indexed citations
6.
Mazumder, Rupa, Avijit Mazumder, Rajesh Kumar Singh, et al.. (2024). Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes. All Life. 17(1). 1 indexed citations
7.
Mazumder, Rupa, et al.. (2024). Discovery of novel CDK4/6 inhibitors from fungal secondary metabolites. International Journal of Biological Macromolecules. 282(Pt 2). 136807–136807. 5 indexed citations
8.
Mazumder, Rupa, et al.. (2024). Identification of Novel CDK 4/6 Inhibitors by High-throughput Virtual Screening. Letters in Drug Design & Discovery. 21(15). 3229–3246. 4 indexed citations
9.
Mazumder, Rupa, et al.. (2024). Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic Targets. Current Drug Targets. 25(15). 1012–1026. 2 indexed citations
10.
Mishra, Rakhi, et al.. (2023). Design, Synthesis, Characterization, and Anti-Cancer Activity Evaluation of Novel Thiosemicarbazide Analogs. Indian Journal of Pharmaceutical Education and Research. 57(1). 210–217. 2 indexed citations
11.
Mazumder, Rupa, et al.. (2023). In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening. Current Drug Discovery Technologies. 21(3). 20–31.
12.
Pal, Rashmi Saxena, et al.. (2023). Multifaceted Understandings of Cancer: A Review of Disease Mechanisms and Therapies. Current Cancer Therapy Reviews. 20(5). 481–488. 1 indexed citations
13.
14.
Mazumder, Rupa, et al.. (2022). PD 1: A Trending Target in Anti-cancer Research. Biointerface Research in Applied Chemistry. 13(3). 218–218. 2 indexed citations
15.
Kumar, Rajnish, et al.. (2022). Insights into Interactions of Human Cytochrome P450 17A1: A Review. Current Drug Metabolism. 23(3). 172–187. 11 indexed citations
16.
Mishra, Rakhi, et al.. (2021). An Updated Review on Synthesis and Biological Activities of Thiosemicarbazide Analogs. Asian Journal of Chemistry. 33(9). 1957–1975. 1 indexed citations
17.
Paul, Swarnali Das, et al.. (2013). An Ex vivo study of Amphotericin-B Nanoparticle for Ocular Delivery. 1(2). 119–125. 1 indexed citations
18.
Mazumder, Rupa, et al.. (2013). FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE. Asian Journal of Pharmaceutical and Clinical Research. 6(7). 31–36. 4 indexed citations
19.
Islam, MR, et al.. (2012). Molecular characterization of inbred and hybrid rice genotypes of Bangladesh.. SABRAO Journal of Breeding and Genetics. 44(1). 163–175. 6 indexed citations
20.
Mazumder, Rupa, et al.. (2004). Antiviral potentiality of methanolic extracts of different parts of Mesua ferrea.. 20(2). 31–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sahabjada Siddiqui Breakdown of academic impact, for papers by Satish Sardana Breakdown of academic impact, for papers by D.N. Prasad Breakdown of academic impact, for papers by Roxana Ghiulai Breakdown of academic impact, for papers by Hezhong Jiang Breakdown of academic impact, for papers by Manikanta Murahari Breakdown of academic impact, for papers by Rajesh B. Patil Breakdown of academic impact, for papers by Camelia Oprean Breakdown of academic impact, for papers by Pritam Jain Breakdown of academic impact, for papers by Chwan‐Fwu Lin
Rankless by CCL
2026